Janice Suchyta
Practice Expertise
- Health Care
Areas of Practice
- Health Care
Profile
Janice Suchyta is a Partner in the Firm's Dallas office and a member of the Health Care & Life Sciences practice group. She represents clients in the health care industry, focusing her practice on the strategic, regulatory and operational needs of health systems, hospitals, academic medical centers, Federally Qualified Health Centers (FQHCs), telehealth providers, and digital start-ups. Her experience as in-house counsel for a large health center provides clients with a unique perspective to navigate complex health care matters.
Ms. Suchyta provides strategic and regulatory guidance on the 340B Drug Discount Program, including contract pharmacy arrangements, as well as limited distribution network and other specialty pharmacy models. She has represented specialty pharmacies, health care systems, hospitals, federal grantees, and other 340B covered entities. She routinely represents FQHCs and rural health centers on compliance and regulatory matters related to the Health Center Program. She advises health centers regarding HRSA Operational Site Visits and other government agency audits, billing and contracting advice, guidance on Federal Tort Claims Act coverage and the 340B Drug Discount Program.
Ms. Suchyta also advises digital and medical technology companies and providers on privacy and security matters. The increased use of Software as a Medical Device (MaSD) and artificial intelligence in medical technology presents unique cyber security issues as the FDA and FTC continue to implement regulatory requirements. Ms. Suchyta provides strategic advice to her medical technology clients on cybersecurity, privacy and data protection issues. She has extensive experience advising health care providers and organizations on Medicare and Medicaid reimbursement matters, including regulatory compliance, billing disputes and audit responses. She also counsels hospitals and physician groups on health plan contracting, including negotiating provider agreements, value-based reimbursement models and managed care arrangements. Ms. Suchyta has presented to national ACO organizations regarding value-based care models, including Direct To Employer arrangements.
Ms. Suchyta routinely represents telehealth providers on licensure, credentialing, privileging, online prescribing and corporate practice of medicine matters. She drafts and reviews contracts for digital health products and services and assists health care clients with security and risk analysis obligations under federal and state laws.
Janice Suchyta advises healthcare providers and medical technology companies on the legal, regulatory, and governance challenges posed by artificial intelligence in healthcare. Her practice focuses on HIPAA and data-privacy compliance, AI-enabled healthcare contracting, and risk-based governance frameworks for the development and deployment of clinical and operational AI tools. She regularly represents hospitals, physician groups, and FQHCs, as well as AI and digital health vendors, in structuring compliant data-use strategies, negotiating complex technology agreements, and addressing regulatory, reimbursement, and enforcement risk associated with AI-driven healthcare solutions.
Janice counsels clients on the development, implementation, acquisition, and commercialization of AI and machine learning technologies in the health care sector. She advises on regulatory compliance issues involving HIPAA, HITECH, state health privacy laws, data governance, cybersecurity, OCR enforcement risks, algorithmic bias, AI governance frameworks, FDA considerations, reimbursement implications, and contractual risk allocation. She also works extensively with health care providers and technology companies on AI-related vendor agreements, business associate agreements, data use agreements, software licensing, API integration arrangements, and health information exchange issues.
Her experience includes advising clients on the use of generative AI and automation technologies in clinical operations, coding and billing functions, utilization review, patient engagement, care coordination, and digital health platforms. Janice also regularly advises on privacy and security risks associated with cloud-based health applications, AI-enabled patient portals, offshore workforce arrangements, and the aggregation and use of electronic health record data.
In addition, Janice provides strategic guidance regarding AI governance and compliance program development for health care organizations, including policies relating to AI oversight, data privacy, workforce use of AI tools, cybersecurity safeguards, and responsible use frameworks. She frequently counsels clients on emerging federal and state regulation affecting AI in health care, including OCR guidance, FTC enforcement trends, state consumer privacy laws, and evolving standards relating to algorithmic accountability and automated decision-making.
A nationally recognized speaker and author on health care AI and digital health regulation, Janice regularly presents on topics involving ethical and regulatory limits on AI in medicine, HIPAA and AI compliance, digital health platform risk, reimbursement implications of AI technologies, and emerging privacy and cybersecurity obligations for health care organizations and technology vendors.
Show MoreShow Less
Ms. Suchyta provides strategic and regulatory guidance on the 340B Drug Discount Program, including contract pharmacy arrangements, as well as limited distribution network and other specialty pharmacy models. She has represented specialty pharmacies, health care systems, hospitals, federal grantees, and other 340B covered entities. She routinely represents FQHCs and rural health centers on compliance and regulatory matters related to the Health Center Program. She advises health centers regarding HRSA Operational Site Visits and other government agency audits, billing and contracting advice, guidance on Federal Tort Claims Act coverage and the 340B Drug Discount Program.
Ms. Suchyta also advises digital and medical technology companies and providers on privacy and security matters. The increased use of Software as a Medical Device (MaSD) and artificial intelligence in medical technology presents unique cyber security issues as the FDA and FTC continue to implement regulatory requirements. Ms. Suchyta provides strategic advice to her medical technology clients on cybersecurity, privacy and data protection issues. She has extensive experience advising health care providers and organizations on Medicare and Medicaid reimbursement matters, including regulatory compliance, billing disputes and audit responses. She also counsels hospitals and physician groups on health plan contracting, including negotiating provider agreements, value-based reimbursement models and managed care arrangements. Ms. Suchyta has presented to national ACO organizations regarding value-based care models, including Direct To Employer arrangements.
Ms. Suchyta routinely represents telehealth providers on licensure, credentialing, privileging, online prescribing and corporate practice of medicine matters. She drafts and reviews contracts for digital health products and services and assists health care clients with security and risk analysis obligations under federal and state laws.
Janice Suchyta advises healthcare providers and medical technology companies on the legal, regulatory, and governance challenges posed by artificial intelligence in healthcare. Her practice focuses on HIPAA and data-privacy compliance, AI-enabled healthcare contracting, and risk-based governance frameworks for the development and deployment of clinical and operational AI tools. She regularly represents hospitals, physician groups, and FQHCs, as well as AI and digital health vendors, in structuring compliant data-use strategies, negotiating complex technology agreements, and addressing regulatory, reimbursement, and enforcement risk associated with AI-driven healthcare solutions.
Janice counsels clients on the development, implementation, acquisition, and commercialization of AI and machine learning technologies in the health care sector. She advises on regulatory compliance issues involving HIPAA, HITECH, state health privacy laws, data governance, cybersecurity, OCR enforcement risks, algorithmic bias, AI governance frameworks, FDA considerations, reimbursement implications, and contractual risk allocation. She also works extensively with health care providers and technology companies on AI-related vendor agreements, business associate agreements, data use agreements, software licensing, API integration arrangements, and health information exchange issues.
Her experience includes advising clients on the use of generative AI and automation technologies in clinical operations, coding and billing functions, utilization review, patient engagement, care coordination, and digital health platforms. Janice also regularly advises on privacy and security risks associated with cloud-based health applications, AI-enabled patient portals, offshore workforce arrangements, and the aggregation and use of electronic health record data.
In addition, Janice provides strategic guidance regarding AI governance and compliance program development for health care organizations, including policies relating to AI oversight, data privacy, workforce use of AI tools, cybersecurity safeguards, and responsible use frameworks. She frequently counsels clients on emerging federal and state regulation affecting AI in health care, including OCR guidance, FTC enforcement trends, state consumer privacy laws, and evolving standards relating to algorithmic accountability and automated decision-making.
A nationally recognized speaker and author on health care AI and digital health regulation, Janice regularly presents on topics involving ethical and regulatory limits on AI in medicine, HIPAA and AI compliance, digital health platform risk, reimbursement implications of AI technologies, and emerging privacy and cybersecurity obligations for health care organizations and technology vendors.
Show MoreShow Less
Education
University of Detroit, Mercy School of Law, J.D.
University of Michigan, B.A. in English Language and Literature
Areas of Practice
- Health Care
Professional Career
Articles
Janice Suchyta, Speaker at National Association of ACOs Spring Conference
Janice Suchyta, Speaker at HFMA 2023 Summer Conference
Janice Suchyta, Speaker at Texas Capital Bank
Janice Suchyta, Speaker at ACO Essentials event
From Discounts to Rebates: The Next Chapter in 340B
From PHI to AI What Texas SB 1188 Means for Healthcare Entities and Vendors
Medi-Cal Rx Issues New 340B Claim Submission Requirements
New HIPAA Requirement: Updated Notice of Privacy Practices
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
Hidden Risks in Medical Technology Contracts - Evergreen Clauses and Undisclosed AI Use
Before You Sign: Red Flag Issues For Healthcare Companies and AI Vendor Contracts
Buchalter Attorneys Speaking at Arizona State University GETS Conference, May 2026
Janice Suchyta Speaking at American Health Law Association
Janice Suchyta, Speaker at HFMA 2023 Summer Conference
Janice Suchyta, Speaker at Texas Capital Bank
Janice Suchyta, Speaker at ACO Essentials event
From Discounts to Rebates: The Next Chapter in 340B
From PHI to AI What Texas SB 1188 Means for Healthcare Entities and Vendors
Medi-Cal Rx Issues New 340B Claim Submission Requirements
New HIPAA Requirement: Updated Notice of Privacy Practices
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
Hidden Risks in Medical Technology Contracts - Evergreen Clauses and Undisclosed AI Use
Before You Sign: Red Flag Issues For Healthcare Companies and AI Vendor Contracts
Buchalter Attorneys Speaking at Arizona State University GETS Conference, May 2026
Janice Suchyta Speaking at American Health Law Association
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.